tirzepatide side effects caused roughly half as many patients to stop treatment because of gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Mounjaro Side Effects: A Week-by-Week

Frontiers in Pharmacology , 13

Step 3: Caffeine restriction and timing

Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG , Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA

The United Kingdom Prospective Diabetes Study (UKPDS) 80 reported that intensive treatment of hyperglycemia considerably reduced the risk of myocardial infarction and death in patients with early diagnosed T2DM followed up during a 10-year post-trial period [3]

Current data supports the safety of long-term Semaglutide use